… -related (iatrogenic) systemic immunosuppression, long-… in Immunology (Systemic and
local immunosuppression in … , namely, tumor-related immunosuppression at baseline and the …

… Systemic lupus erythematosus (SLE) is a prototypical systemic autoimmune disease (AD) …
Supported by preclinical models, highdose immunosuppression followed by transplantation …

… may vary and can ultimately lead to systemic inflammation and the subsequent signs and …
in the current paradigm shift toward more attention for the immunosuppressive phase of sepsis …

… against cancer cells and less systemic toxicities. However, like … Recently, a paradigm
shift has been brought to the clinic with … Another unexpected immunosuppressive effect on …

… of a systemic immune response. Although the local immunosuppression mediated by metastatic
… not normally lead to complete systemic immunosuppression, this process nevertheless …

Harnessing an antitumor immune response has been a fundamental strategy in cancer
immunotherapy. For over a century, efforts have primarily focused on amplifying immune …

… of oncolytic viruses for initiating systemic antitumor activity and … , where the degree of
immunosuppression should be high … is still evident, systemic glucocorticoids should be …

… systemic immunosuppressive drugs. In rodents, corneal allografts transplanted across entire
MHC and multiple minor histocompatibility barriers enjoy long-term survival in >50% of the …

… immunosuppressive … immunosuppressive drug used clinically to lower the rate of
immunological rejection after solid organ transplantation [3]. It is well known that its …

… methodological approach and ensuing classification system using anti-nuclear antibodies
as an entry criterion and weighted, hierarchically clustered criteria, constitute a paradigm shift …